1[1]Zülch KJ. Histologic typing of tumours of the central nervours system. Geneva, Switzerland: World Health Organization, 1979
2[2]Kleihues P. Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin, Heidelberg: Springer Verlag, 1993
3[3]Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3:255 ～ 268
4[4]Hamilton SR, Aaltonen LA. World Health Organisation Classification of Tumours: pathology and genetics of tumours of the digestive system. Lyon, Franse: IARC Press, 2000
5[5]Kleihues P, David N, Louis DN, etal. The WHO classification of tumors of the nervors system. Journal of Neuropathology and Experimental Neurology 2002;61:215 ～ 225
6[7]Perry A, Scheithauer BW, Stafford SL, et al. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients with grading implications. Cancer 1999; 85:2046 ～ 2056
7[8]Perry A, Stafford SL, ScheithauerBW, et al. Meningioma grading:an analysis of histologic parameters. Am J Surg Pathol 1997; 21:1455～ 1465
8[9]Kallio M, Sankia R, Hakulinen T, et al. Factors affecting operative and excess long - term mortality in 935 patients with intracranial meningioma. Neurosurgery 1992; 31: 2 ～ 12
9[10]Maier H, Ofner D, Hittmair A, et al. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77:616 ～ 623
10[11]Rempel Sa, Schwechheimer K, Davis RL, et al. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 1993; 53:2386 ～2392
